There is a considerable body of evidence suggesting that secretion and blood flow in the stomach vary together (1) (2) (3) (4) (5) (6) and an equally impressive array of studies that speaks against such a relationship (7) (8) (9) (10) (11) . In attempting to evaluate a possible relationship between gastric blood flow and secretion we are confronted with problems that are basically methodological (12) . Nearly all of the investigations cited have been either acute experiments on anesthetized and traumatized animals or chronic observations of unanesthetized humans in which nonspecific gastric mucosal changes have been used to gauge gastric blood flow. In the acute experiments both blood flow and secretion are subject to the profound but unmeasured influences of anesthetics and surgical stress, which can camouflage a relationship. In the chronic studies the color or temperature of the mucosa or the size of microcirculatory vessels has been used as an "index" of mucosal blood flow. Unfortunately these indexes do not measure blood flow: mucosal color and vessel size are estimates of mucosal blood volume, and mucosal temperature reflects deep body temperature, not blood flow. In short, the available evidence on the subject of a relationship between blood flow and secretion in the stomach comes from experiments in which either the state of the preparation or the methods of measuring blood flow was unreliable.
We established four requirements that we felt would have to be satisfied for a study of gastric secretory and circulatory function to yield infor-mation that would not be subject to the preceding criticisms: 1) the animal must be unanesthetized and weeks past surgery; 2) both gastric secretion and blood flow must be measured simultaneously, and the measurement of one function must not interfere with measurement of the other; 3) frequent or continuous measurements of blood flow and secretion must be obtained for considerable periods to obviate the effect of normal fluctuations; and 4) the method of measuring blood flow must quantify gastric mucosal flow, since this can vary independently of total blood flow to the stomach.
For these reasons we selected a gastric clearance technic first described by Shore, Brodie, and Hogben (13) . The method is based upon the selective permeability of lipoidal membranes to the undissociated form of compounds. Since there is a sizeable pH gradient from plasma to gastric juice, weakly basic drugs with a suitable pKa (5 to 10) will be transported from the plasma and will accumulate in the secretions of the stomach. The theoretical ratio (R) of the concentration of these drugs in gastric juice/plasma, if we assume no limitation on the rate at which the drug is delivered to the membrane by the circulation, can be calculated from the equation, R 1 + JOPKa-gastric juice pH 1 + lOPKa-plasma pH For weak bases with pKa less than 2, the theoretical R (diffusion limited only) was identical with the observed R. However, for aminopyrine (pKa = 5) the theoretical R would be approximately 104, whereas the observed R was 40, suggesting that blood flow is not infinitely fast and that it limits the transit of aminopyrine by the rate at which it delivers the drug to the membrane (13) . If blood flow is a factor that limits R, then aminopyrine is suited as a clearance marker for estima-tion of mucosal blood flow and should meet the requirements of the Fick principle.
A basic assumption of the use of this clearance technic for estimating blood flow is that the mucosa completely clears the drug from the circulation on a single passage through that tissue which is exposed to acid gastric juice. This assumption cannot be tested directly, since venous blood from the stomach drains nonmucosal structures as well as the mucosa. However, as will be developed in this presentation, several considerations make this assumption acceptable.
Methods
Unanesthetized dogs. Vagally denervated gastric fundic (Heidenhain) pouches were prepared in 12 mongrel dogs of both sexes weighing from 13 to 17 kg. No experiments were performed during the first 3 weeks after surgery. Frequent hematocrit determinations were obtained in each dog because of the depressive effects of aminopyrine on canine bone marrow (pancytopenia) (14) . Two of the animals developed a profound chronic anemia after their initial exposure to aminopyrine, and these dogs were not used further. The other ten animals showed no significant alteration in hematocrit despite administration of as much as 40 mg of aminopyrine per kg body weight during each of five separate experiments spaced over 3 months.
A typical experiment consisted of placing the dogs in a sling frame and starting a constant infusion of saline into a hind leg vein at a rate of 0.5 ml per minute by means of a peristaltic pump.' A loading dose (20 mg per kg) of aminopyrine was infused over 10 minutes, and then a maintenance dose (5 mg per kg per hour) was continued throughout the experiment to stabilize plasma aminopyrine concentrations. After 30 minutes, during which the pouch was not secreting spontaneously, a small amount of histamine (0.1 mg base per hour) or porcine gastrin (5 g per hour) was added to the infused material to initiate a submaximal secretory rate. After 1 hour the dose of the stimulant was doubled, followed by successive doublings of the dose each hour until the secretory rate no longer increased with increments in drug dosage (maximal response). At this point bethanechol (0.5 mg) was infused for 1 hour, along with the maximal dose of histamine or gastrin, to induce a supramaximal secretory response (15) . In some experiments a steady submaximal secretory response was maintained with histamine or gastrin, and a secretory inhibitory agent (vasopressin, epinephrine, isoproterenol, or secretin) was added to observe the effect of these agents on both secretion and clearance.
The dosages of the various agents infused were as fol- (17) . This technic consists essentially of alkalinizing a 1-ml biological sample, extracting aminopyrine into dichloroethane solvent, washing with sodium borate, and extracting aminopyrine back into an aqueous acid phase. The concentration of drug is then determined by its absorption at 560 mtu in a Zeiss spectrophotometer. In our hands the limit of detection of aminopyrine was 1 og in a 1-ml sample of either gastric juice or plasma. In 30 pairs of consecutive duplicate samples from our experiments, the standard deviation of the mean of paired samples was 0.6 ,ug per ml.5 These results compare favorably with the limits of the method as originally described by Brodie and Axelrod (17) . This method measures not only aminopyrine but also one of its metabolites, 4-amino antipyrine. In our experience, however, the concentration ratio of substances in gastric juice and plasma measured by this method remained remarkably constant under constant experimental conditions. Furthermore, Shore and co-workers (13) measured aminopyrine concentrations in gastric juice and plasma under conditions similar to our experiments and observed an R for aminopyrine alone that was nearly the same as the R we found.
Our recoveries of aminopyrine from canine plasma and gastric juice were not significantly different from recoveries from distilled water (over 97%9), again agreeing with the original report for this method (17) .
Brodie and Axelrod also found that whole blood aminopyrine concentrations were 85%o of the plasma value.
The clearance, which can be assumed to represent pouch mucosal plasma flow, was calculated from the relationship, C = GV/P, where C is the clearance (milliliters per minute), G (19) . aminopyrine concentration (milligrams per milliliter), and V is the gastric secretory rate (milliliters per minute).
The ratio of G/P, which is designated as R, is of more than passing interest (13, 20, 21) . It expresses the limitation imposed by the circulation on the transit of weak base across the gastric mucosal membrane. In other words, R tells us how much plasma flow in the mucosa occurred per unit of secretory volume. For these reasons both clearance and R will be compared with gastric secretory rate in our results.
Results
The gastric clearance technic Studies in anesthetized dogs. In two acute experiments on anesthetized dogs we found that there was no significant arteriovenous concentration difference for aminopyrine in the following circulatory areas: small intestine, brain and head, kidney, heart and lungs, and forelimb. By contrast, in seven other acute experiments the stomach cleared 58% (range, 44 to 75%) of the aminopyrine from the blood presented to it. These determinations were made at the end of 30 minutes stimulation with histamine.
We compared the amount of aminopyrine secreted by the total stomach in 1 hour with the amount of drug cleared simultaneously from the blood perfusing the stomach (product of stomach blood flow and arteriovenous concentration differ- (22) . In each experiment over 90%o of the extracted aminopyrine was recovered in the gastric juice.
Studies in unanesthetized dogs. Aminopyrine as used in our experiments did not affect gastric secretion. In two dogs ( Figure 1 ) a stable secretory rate was established with histamine, and the infusion of aminopyrine did not alter either the volume rate of secretion or the acid concentration of gastric juice.
When a constant stimulus to gastric secretion was used and a constant amount of aminopyrine infused to maintain stable plasma concentrations, we observed no significant changes in R values over many hours. This relative constancy of R was noted not only when gastric secretions were allowed to drain freely to the exterior but also when pouch secretions were kept in constant contact with the mucosa. This steady state for R suggested that reabsorption of aminopyrine from the pouch must be minimal. This possibility was investigated in 22 experimental periods of 30 minutes each in three different animals. We kept a 50-ml solution containing 1 mg per ml aminopyrine in 0.1 N HCO (this corresponds to the concentrations of aminopyrine and HCO secreted during our experiments) in contact with the pouch mucosa during each of the experimental periods. Recovery of aminopyrine from pouch solutions in these 22 periods was 96 + 1%o (SE) of that instilled, which was not significantly different from 100% (p > 0.1).
The effect of varying the pH of the pouch solution on aminopyrine clearance was examined during seven experiments on six animals. A constant dose of aminopyrine was administered throughout each experiment, and the different solutions were GASTRIC SECRETORY VOLUME RATE (ml/15min) Figure 3 . It can be seen that secretion and clearance exhibit a significant positive correlation (r = 0.95, p < 0.01) over the range of minimal to maximal secretory response to histamine.
A comparison of secretory rates and R in the same experiments (Figure 4 ) again demonstrates the high R values at low secretory rates, the decline in R as secretion increases, and the plateau of R in the neighborhood of 30 as maximal and supramaximal secretory rates are achieved in the pouch.
Gastrin. Simultaneous gastric secretory a-id circulatory responses to different doses of gastlin and to gastrin and bethanechol in one animal are shown in Figure 5 . The maximal secretory response to gastrin was attained at a dosage of 10 g per hour; no further secretory increment was observed when 40 g per hour was administered; however, addition of bethanechol to gastrin induced a supramaximal secretory response. The changes of mucosal blood flow, as estimated by the clearance, corresponded quite well to the changes in secretion, both in direction and magnitude. R showed a decrease as secretion was increasing from low levels and then remained fairly steady at 30 to 40 throughout the remainder of the experiment.
Graphic comparison of secretory volume rate and plasma clearance in six experiments with gastrin is shown in Figure 6 . The scatter is somewhat greater than for histamine (r = 0.85, p < 0.01). However, as with histamine, when secretory rate increased, clearance increased.
A plot of R as a function of secretory rate for all gastrin experiments reveals, as with histamine, the same rapid decay in R as secretory rate rose 10 12 from minimal values with a plateau at 30 to 40 in :ml/15min) the maximal and supramaximal secretory range cosal plasma clearance, and R during background stimulation with a fixed dose of histamine was observed in three animals, and results from one experiment are shown in Figure 8 . The expected inhibition of secretion induced by the administration of vasopressin was associated with a parallel decline in clearance and a slight rise in R. After cessation of the vasopressin, secretion and mucosal blood flow increased, whereas R exhibited a return toward prevasopressin values. A plot of secretion versus clearance in the experimental periods during which vasopressin and histamine were administered together is shown in Figure 9 . Since vasopressin inhibited secretion so effectively, the range of values is restricted to low secretory and blood flow rates. Nevertheless, comparison of these values with similar secretoryclearance points during administration of histamine alone ( Figure 3 ) reveals little overlap between groups. With vasopressin and histamine higher secretory rates were associated with an increased blood flow (r = 0.95, p < 0.01). b) Isoproterenol. Inhibition by isoproterenol of submaximal gastric secretory rates maintained with infusion of histamine was investigated in seven animals. Results from one experiment using two doses of the sympathomimetic dilator appear in Figure 10 . At the lower dose the drug did c) Epinephrine. The effects of epinephrine during background stimulation with gastrin) on gastric secretion, clearance, and R were observed in three dogs. Typical results ( Figure 11 ) were an inhibition of both secretion and clearance and an increase in R during the interval of epinephrine infusion, and a return toward precatecholamine values after cessation of epinephrine. The scatter of values for secretion versus clearance during experimental periods when the two drugs were delivered together is shown in Figure 12 . Changes in secretory rate were associated with directionally corresponding changes in clearance (r = 0.94, p < d) Secretin. The action of secretin on gastric secretion, clearance, and R was observed in three animals, and results from one experiment appear in Figure 13 . The hormone inhibited secretion and clearance and induced a rise in R. These effects were not entirely gone 1 hour after the last secretin injection. Results from these three experiments (Figure 12 ) demonstrate that during periods of administration of both secretin and ,gastrin changes in secretion correlated well with changes in clearance (r = 0.93, p < 0.01). Discussion The findings of our study indicate that secretion and blood flow are related in the stomach. There are, however, other reports that present evidence against such a relationship, namely that known secretory stimuli did not increase gastric blood flow and known inhibitors of secretion failed to decrease blood flow to the stomach (7) (8) (9) (10) (11) . In four of these reports (7) (8) (9) (10) anesthetized and even hypotensive animals were used, which may account for some of the discrepancies among these papers: histamine was observed to increase (11) , to decrease (8) , and not to alter gastric blood flow (7, 10) ; epinephrine was found to increase (10, 11) and to decrease (7, 8) Our results strongly support a positive relationship between gastric secretion and blood flow. In a large number of experiments with seven different drugs that affect gastric secretion, we consistently observed this relationship: as gastric secretion changed, gastric mucosal blood flow (as estimated by clearance) changed correspondingly. Results with the stimulatory agents histamine, gastrin, and bethanechol appear to us to be the most clear-cut; dose-response relationships obtained about as well for clearance as for secretory rate. In the experiments with gastric secretory inhibitors, results were more complex, as for example the different effects of vasopressin and isoproterenol on R when both agents depressed secretion and clearance. The results from these inhibitory experiments, however, still support a positive correlation between secretion and blood flow (Figures 9 and 12) .
The ratio (R) of gastric juice to plasma aminopyrine concentrations declined to a plateau value in the range of 30 to 40 when secretion achieved moderate to maximal rates, but was considerably higher than 40 when small doses of histamine or gastrin were employed. This plateau value for aminopyrine is similar to what Shore and his associates (13) reported with a maximal stimulatory dose of histamine. We also noted that during inhibition of secretion, especially with the catecholamines and secretin, R became markedly elevated. We have interpreted R as an indicator of the limitation imposed by the circulation on the transit of poorly ionized drugs across the stomach. R may be interpreted further as the number of unit volumes of mucosal blood that have flowed during the formation of one unit volume of secretion under a given set of conditions. Thus, a high R indicates that blood flow is disproportionately high in relation to secretion, a condition seen at low secretory rates with low doses of stimulants, or with secretory inhibitors (e.g., secretin, catecholamines) that do not limit blood flow, or with an agent that vasodilates without inhibiting secretion (low dose of isoproterenol in Figure 10 ). At high secretory rates induced by high doses of stimulants, R declines to a fixed plateau value, probably representing the situation in which secretion is blood flow limited, and further increments in secretory rate will require 30 to 40 ml blood flow for each ml of gastric juice that will be secreted.
If our inference that secretion and mucosal blood flow are normally related is valid, the next consideration is one of assessing whether secretory changes determine blood flow or the reverse. Our evidence does not allow a definitive answer to the nature of the secretory-circulatory relationship in the stomach; however, from our experiments with isoproterenol ( Figure 10) , it seems that blood flow can increase significantly without a corresponding increment in secretion. On the other hand, we have not observed significant secretory changes without corresponding directional changes in clearance. Secretion and blood flow in the stomach appear to be related in two major ways: 1) secretory changes determine directionally corresponding changes in the gastric mucosal circulation, and 2) various conditions of stimulation and inhibition can act to alter the amount of blood flow associated with a unit volume of secretion. In other words, it appears as if secretory changes induce corresponding circulatory alterations, but the reverse relationship, that is, alteration of secretion by a change in blood flow, is seen only when blood flow is reduced to a limiting value.
The major assumption of this clearance technic, namely that extraction is high and stable, remains to be proved. The extraction ratio for aminopyrine cannot be determined directly because pure gastric mucosal venous blood cannot be sampled. If the extraction ratio for aminopyrine varied greatly with different experimental conditions, then the clearance of aminopyrine would not be a valid method for measuring gastric mucosal blood flow, and the subscripts t, m, and nm represent togastric extraction of aminopyrine was 58%. Using this value we can relate extraction to flow in the stomach, as Et = (Em Fm + Enm Fnm)/ (Fm + Fnm), where E is extraction, F is plasma flow, and the subscripts t, m, and nm represent total, mucosal, and nonmucosal, respectively. If we assume that nonmucosal gastric tissue does not extract aminopyrine, then it follows that with an ob- In our experiments the ratio of gastric juice to plasma aminopyrine concentrations (R) was found to vary from 20 to 175 (Figures 4 and 7) . This eightfold range of R values, and the even larger range of mucosal blood flow values could be explained on the basis of a variation in the relationship between mucosal blood flow and secretion or a variation in extraction ratio. As the preceding discussion indicates, an eightfold variation in extraction ratio is not possible.
It is possible that aminopyrine is actively secreted by the gastric mucosa. Our finding that stimulation of gastric secretion increases the amount of aminopyrine accumulating in the lumen of the stomach would support this possibility.
The data appear at face value to show that secretory rate and clearance are inseparable. If this possibility were correct, a corollary would be that the gastric mucosa presents high resistance to pas-sive diffusion, clears aminopyrine incompletely from the blood, and accomplishes this clearance mainly by active transport. This alternative explanation cannot be refuted directly; however, the diversity of chemical compounds that can be concentrated by the stomach makes it unlikely that there is an active transport mechanism involving specific chemical reactions (13) . Furthermore, we have found that altering the pH of solutions instilled into the pouch lumen markedly changes the amount of aminopyrine that will cross from blood to lumen in the nonsecreting stomach. Our experiments with low doses of isoproterenol (Figure 10) show one situation, at least, in which clearance can be raised without increasing secretion. Finally, as we have discussed previously, clearance from the mucosa cannot be far from complete.
Summary
The relationship between secretion and mucosal blood flow was investigated in the stomach of unanesthetized dogs provided with denervated pouches. Gastric mucosal blood flow was estimated by aminopyrine clearance.
Secretion and mucosal blood flow were studied during administration of varying amounts of histamine or porcine gastrin, and of combinations of these stimuli with bethanechol, vasopressin, isoproterenol, epinephrine, or secretin. Under all conditions of stimulation and inhibition, clearance varied directly with secretory rate; however, for some situations (e.g., isoproterenol plus histamine) mucosal blood flow per unit of secretion was higher than for other situations (e.g., vasopressin plus histamine). From 
